Kubasek; William

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kubasek; William.The latest application filed is for "methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted response".

Company Profile

1.5.15

Kubasek; William - Belmont MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or chemotherapies Grant 10,273,304 - Adiwijaya , et al.	2019-04-30
Methods, Systems And Products For Predicting Response Of Tumor Cells To A Therapeutic Agent And Treating A Patient According To The Predicted Response App 20170307631 - SCHOEBERL; Birgit ; et al.	2017-10-26
Biomarker Profiles For Predicting Outcomes Of Cancer Therapy With Erbb3 Inhibitors And/or Chemotherapies App 20170267767 - ADIWIJAYA; Bambang ; et al.	2017-09-21
Biomarker Profiles For Predicting Outcomes Of Cancer Therapy With Erbb3 Inhibitors And/or Chemotherapies App 20170210810 - ADIWIJAYA; Bambang ; et al.	2017-07-27
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or chemotherapies Grant 9,688,761 - Adiwijaya , et al. June 27, 2	2017-06-27
Biomarker Profiles For Predicting Outcomes Of Cancer Therapy With Erbb3 Inhibitors And/or Chemotherapies App 20160090418 - ADIWIJAYA; Bambang ; et al.	2016-03-31
Overcoming Resistance To Erbb Pathway Inhibitors App 20150231238 - Garcia; Gabriela ; et al.	2015-08-20
Anti-erbb3 Antibodies In Combination With Paclitaxel For Treatment Of Gynecological Cancers App 20140248280 - Kubasek; William ; et al.	2014-09-04
Methods For Preventing Toxic Drug-drug Interactions In Combination Therapies Comprising Anti-erbb3 Agents App 20140234317 - Onsum; Matthew David ; et al.	2014-08-21
Use Of Inhibitors Of Egfr-family Receptors In The Treatment Of Hormone Refractory Breast Cancers App 20140134170 - Garcia; Gabriela ; et al.	2014-05-15
Methods, Systems And Products For Predicting Response Of Tumor Cells To A Therapeutic Agent And Treating A Patient According To The Predicted Response App 20140127238 - SCHOEBERL; Birgit ; et al.	2014-05-08
Methods and systems for predicting response of cells to a therapeutic agent Grant 8,623,592 - Schoeberl , et al. January 7, 2	2014-01-07
Methods And Systems For Predicting Response Of Cells To A Therapeutic Agent App 20110159513 - Schoeberl; Birgit ; et al.	2011-06-30
Methods, Systems And Products For Predicting Response Of Tumor Cells To A Therapeutic Agent And Treating A Patient According To The Predicted Response App 20110027291 - SCHOEBERL; Birgit ; et al.	2011-02-03
A.beta. peptides that modulate .beta.-amyloid aggregation Grant 5,854,204 - Findeis , et al. December 29, 1	1998-12-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.